CELER (=Cesar Letrozol Randomized Phase III)Study
Laufzeit: 01.01.2005 - 31.12.2007
imported
Kurzfassung
First-Line Treatment of Postmenopausal Patients with Endocrine Responsive Metastatic Breast Cancer. A Randomized, Multicenter Study Comparing Letrozol Combined with Standard Chemotherapy Vs Letrozol Single Agent